The Food and Drug Administration approved Moderna's RSV vaccine to prevent lower respiratory tract disease in adults aged 60 or older ...
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only ...
Moderna’s shot is the third RSV vaccine for people 60 and older that’s gotten the green light from the FDA and the first mRNA ...
After years of inertia, the field of research into the health effects of marijuana may be about to get a boost. Maybe.
More than 100,000 cases of RSV LRTD in ... priority review status and expects to make a decision by June 15. BMS padded the application with study results showing the drug's ability to achieve ...
This National Foster Care Month, Cardinality.ai ? a data technology company empowering government agencies with innovative, AI-powered solutions ? congratulates the Georgia Department of Human ...
The Cambridge drugmaker’s mRNA vaccine for respiratory syncytial virus, or RSV, got the green light from the FDA on Friday.
The FDA approved mRNA-1345, a Moderna vaccine for the treatment of respiratory syncytial virus (RSV). This single-dose ...
RBC Capital has lowered its rating on Sarepta Therapeutics (NASDAQ:SRPT) to sector perform, citing a run up in the stock ahead of an expected FDA decision on June 21 for its drug Elevidys in the ...
The US Supreme Court handed down two decisions today relating to COVID-19 vaccine mandates, issuing a stay to prevent a broad mandate from the Occupational Health and Safety Administration ...
Respiratory syncytial virus ... of an RSV vaccine. The F protein exists as a trimer in both prefusion and postfusion forms that can elicit neutralizing antibodies. The US FDA-approved monoclonal ...